Citation: N. Borsellino et al., ENDOGENOUS INTERLEUKIN-6 IS A RESISTANCE FACTOR FOR CIS-DIAMMINEDICHLOROPLATINUM AND ETOPOSIDE-MEDIATED CYTOTOXICITY OF HUMAN PROSTATE CARCINOMA CELL-LINES, Cancer research, 55(20), 1995, pp. 4633-4639
Authors:
SARNA G
MACHLEDER H
COLLINS J
BONAVIDA B
JACOBS E
HAWKINS R
GOLUB S
SHAU HY
FAHEY J
POPOW J
ROBERTSON P
AHN S
QUINONES W
Citation: G. Sarna et al., A COMPARATIVE-STUDY OF INTRAVENOUS VERSUS INTRALYMPHATIC INTERLEUKIN-2, WITH ASSESSMENT OF EFFECTS OF INTERLEUKIN-2 ON BOTH PERIPHERAL-BLOOD AND THORACIC-DUCT LYMPH, Journal of immunotherapy with emphasis on tumor immunology, 15(2), 1994, pp. 140-146
Authors:
HOURIZADEH A
BROQUET C
MENCIAHUERTA JM
BRAQUET P
BEREK J
BONAVIDA B
Citation: A. Hourizadeh et al., CYTOTOXICITY OF NEW AZA-ALKYL LYSOPHOSPHOLIPIDS AGAINST DRUG-SENSITIVE AND RESISTANT HUMAN OVARIAN TUMOR-CELL LINES - ROLE OF FREE-RADICALSAND POTENTIATION OF CYTOTOXICITY BY TNF-ALPHA AND CDDP, Oncology Reports, 1(6), 1994, pp. 1253-1259
Authors:
DEMIDEM A
BROQUET C
MENCIAHUERTA JM
SALAHUDDIN SZ
LAM T
KHAN RS
BRAQUET P
LEVINE AM
BONAVIDA B
Citation: A. Demidem et al., SENSITIVITY OF DRUG-RESISTANT B-CELL LINES FROM AIDS-RELATED NON-HODGKINS-LYMPHOMA TO NEWLY SYNTHESIZED PODOPHYLLOTOXIN DERIVATIVES AND AZA-ALKYLLYSOPHOSPHOLIPIDS - ENHANCED SENSITIZATION BY PRETREATMENT WITH INTERFERON-GAMMA, International journal of oncology, 4(6), 1994, pp. 1203-1209
Citation: J. Katz et B. Bonavida, EXPRESSION OF SUPERANTIGEN-LIKE SPECIFICITIES ON MURINE SJL J-B LYMPHOMAS - ANTITUMOR V-BETA-17A+ T-LYMPHOCYTES USE A DIVERSE SET OF T-CELLRECEPTOR V-ALPHA-CHAIN GENE-SEQUENCES/, International journal of oncology, 4(4), 1994, pp. 839-847
Citation: B. Bonavida et al., QUALITATIVE AND QUANTITATIVE-ANALYSIS OF SUBPOPULATIONS OF CYTOTOXIC EFFECTOR-CELLS BY FLOW-CYTOMETRY, Journal of lipid mediators and cell signalling, 9(1), 1994, pp. 19-25
Citation: Y. Mizutani et B. Bonavida, PENTOXIFYLLINE ENHANCES SENSITIVITY OF A HUMAN OVARIAN-CANCER CELL-LINE (OVC-8) TO TNF-ALPHA, Biotherapy, 7(2), 1994, pp. 109-114
Citation: A. Jewett et B. Bonavida, TARGET-CELL MEDIATED INACTIVATION OF HUMAN PERIPHERAL-BLOOD NK CELLS - SPLIT ANERGY AND PROGRAMMED CELL-DEATH IN A SUBSET OF NK CELLS, The FASEB journal, 8(5), 1994, pp. 10000984-10000984
Authors:
GAN XH
ROBIN J
MENCIAHUERTA JM
BRAQUET P
BONAVIDA B
Citation: Xh. Gan et al., INHIBITION OF TNF-ALPHA, IL-1-BETA, AND IL-10 SECRETION BUT NOT IL-6 BY LPS ACTIVATED HUMAN PERIPHERAL-BLOOD MONOCYTES BY A NEW SYNTHETIC DEMETHYLPODOPHYLLOTOXIN DERIVATIVE (BN58705), The FASEB journal, 8(4), 1994, pp. 10000229-10000229
Authors:
DEMIDEM A
BONAVIDA B
SALAHUDDIN Z
LAM T
NAKAMURA S
JEWETT A
Citation: A. Demidem et al., REGULATION OF CELL-PROLIFERATION AND SENSITIZATION TO DRUGS OF HUMAN NON-HODGKINS B-LYMPHOMA CELL-LINES BY ENDOGENOUS CYTOKINES, The FASEB journal, 8(4), 1994, pp. 10000231-10000231
Citation: Dl. Vredevoe et al., RELATIONSHIP BETWEEN NATURAL-KILLER-CELL ANERGY AND PLASMA NOREPINEPHRINE IN HEART-FAILURE, The FASEB journal, 8(4), 1994, pp. 10000481-10000481
Citation: B. Bonavida et Jm. Menciahuerta, PLATELET-ACTIVATING-FACTOR AND THE CYTOKINE NETWORK IN INFLAMMATORY PROCESSES, Clinical reviews in allergy, 12(4), 1994, pp. 381-395
Citation: Y. Mizutani et al., CYTOTOXIC EFFECT OF DIPHTHERIA-TOXIN USED ALONE OR IN COMBINATION WITH OTHER AGENTS ON HUMAN RENAL-CELL CARCINOMA CELL-LINES, Urological research, 22(4), 1994, pp. 261-266
Authors:
GAN XH
ROBIN JP
HUERTA JMM
BRAQUET P
BONAVIDA B
Citation: Xh. Gan et al., INHIBITION OF TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) AND INTERLEUKIN-1-BETA (IL-1-BETA) SECRETION BUT NOT IL-6 FROM ACTIVATED HUMAN PERIPHERAL-BLOOD MONOCYTES BY A NEW SYNTHETIC DEMETHYLPODOPHYLLOTOXIN DERIVATIVE, Journal of clinical immunology, 14(5), 1994, pp. 280-288
Citation: A. Jewett et B. Bonavida, PENTOXIFYLLINE SUPPRESSES INTERLEUKIN-2-MEDIATED ACTIVATION OF IMMATURE HUMAN NATURAL-KILLER-CELLS BY INHIBITING ENDOGENOUS TUMOR-NECROSIS-FACTOR-ALPHA SECRETION, Journal of clinical immunology, 14(1), 1994, pp. 31-38
Citation: Y. Mizutani et al., OVERCOMING TNF-ALPHA AND DRUG-RESISTANCE OF HUMAN RENAL-CELL CARCINOMA-CELLS BY TREATMENT WITH PENTOXIFYLLINE IN COMBINATION WITH TNF-ALPHAOR DRUGS - THE ROLE OF TNF-ALPHA MESSENGER-RNA DOWN-REGULATION IN TUMOR-CELL SENSITIZATION, The Journal of urology, 151(6), 1994, pp. 1697-1702
Citation: A. Jewett et B. Bonavida, ACTIVATION OF THE HUMAN IMMATURE NATURAL-KILLER-CELL SUBSET BY IL-12 AND ITS REGULATION BY ENDOGENOUS TNF-ALPHA AND IFN-GAMMA SECRETION, Cellular immunology, 154(2), 1994, pp. 273-286
Authors:
MIZUTANI Y
FUKUMOTO M
BONAVIDA B
YOSHIDA O
Citation: Y. Mizutani et al., ENHANCEMENT OF SENSITIVITY OF URINARY-BLADDER TUMOR-CELLS TO CISPLATIN BY C-MYC ANTISENSE OLIGONUCLEOTIDE, Cancer, 74(9), 1994, pp. 2546-2554
Authors:
MIZUTANI Y
FUKUMOTO M
BONAVIDA B
YOSHIDA O
Citation: Y. Mizutani et al., ENHANCEMENT OF SENSITIVITY OF URINARY-BLADDER TUMOR-CELLS TO CISPLATIN BY C-MYC ANTISENSE OLIGONUCLEOTIDE, Cancer, 74(9), 1994, pp. 2546-2554
Authors:
MORIMOTO H
ROBIN JP
BROQUET C
MENCIAHUERTA JM
BRAQUET P
BONAVIDA B
Citation: H. Morimoto et al., CYTOTOXIC ACTIVITY AGAINST RESISTANT HUMAN TUMOR-CELL LINES BY 2 SYNTHETIC DEMETHYLPODOPHYLLOTOXIN DERIVATIVES - A SINGLE STEREOISOMERIC CHANGE PREVENTS CELL-DEATH BY APOPTOSIS, International journal of oncology, 3(6), 1993, pp. 1061-1066
Citation: Y. Mizutani et B. Bonavida, OVERCOMING TNF-ALPHA AND CDDP RESISTANCE OF A HUMAN OVARIAN-CANCER CELL-LINE (C30) BY TREATMENT WITH BUTHIONINE SULFOXIMINE IN COMBINATION WITH TNF-ALPHA AND OR CDDP, International journal of oncology, 3(2), 1993, pp. 229-235
Authors:
SOLOMON GF
BENTON D
HARKER JO
BONAVIDA B
FLETCHER MA
Citation: Gf. Solomon et al., PROLONGED ASYMPTOMATIC STATES IN HIV-SEROPOSITIVE PERSONS WITH 50 CD4-CELLS MM(3) - PRELIMINARY PSYCHOIMMUNOLOGICAL FINDINGS( T), Journal of acquired immune deficiency syndromes, 6(10), 1993, pp. 1172-1173
Citation: K. Ohnishi et B. Bonavida, REGULATION OF B-CELL LYMPHOMA GROWTH IN SYNGENEIC SJL J MICE - ESTABLISHMENT OF TUMOR DORMANCY FOLLOWING ADMINISTRATION OF ANTI-CD4 MONOCLONAL-ANTIBODY INTO TUMOR-BEARING MICE/, Leukemia, 7(11), 1993, pp. 1801-1806